Reporter Staff

Reporter Staff

| This email address is being protected from spambots. You need JavaScript enabled to view it.
The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a 75-week research study to evaluate the effectiveness of an investigational drug to treat type 2 diabetes. In this trial you will receive one of two possible once-weekly injectable medications: either semaglutide/cagrlintide (CagriSema) or tirzepatide (Mounjaro) along with diet and exercise counseling. To qualify, you must be 18 years old or older and have Type 2 Diabetes. Qualified participants will receive study drug, diabetes counseling, EKGs, eye exams, and physical exams. There is no charge for participation. Compensation for time and travel may also be available. For more information, and to see if you might be eligible to join, please contact (205)996-4015 or
Are you experiencing pain due to endometriosis? Please consider joining a research study looking at a potential new medication to help women experiencing moderate to severe endometriosis-related pain. Study medication provided at no cost. Participants receive compensation for each visit completed. For more information please call 205-934-1322 or email
About 12% of people in the United States are currently living with herpes simplex virus type 2 (HSV-2) genital herpes. Moderna is sponsoring the Vantage Trial, a clinical trial looking at the safety and immune response of an investigational vaccine to potentially treat HSV-2. Your participation may help advance research of an investigational treatment option for HSV-2—one that aims to treat genital herpes and relieve the burden of daily medication.

If you are living with HSV-2, you may be eligible to join. To learn more, contact the UAB Sexual Health Research Clinic at 205-934-8166.
December 18, 2023

Our best photos of 2023

Each year, UAB’s official photographers capture tens of thousands of images as they document the incredible variety of events and personalities that make up our community. Here are some of our favorite photos from the past 12 months.
UAB faculty and staff share their expertise with patients, students and the community — and their colleagues through the Reporter. These articles are always popular; here are some of the most-viewed of 2023.
UAB faculty and staff are the cornerstone of the university’s successes each year, and your feedback earned UAB its first-ever appearance in the Great Colleges to Work For program in 2023. What else got our Blazer spirit going this year? Read on to jog your memory.
UAB has the only Level IV Regional Newborn Intensive Care Unit in Alabama, a Continuing Care Nursery that provides extended step-down care for preterm and term babies with medical conditions, and a Department of Obstetrics and Gynecology that was ranked No. 13 in the country (and highest in the Southeast) by U.S. News in its 2023-2024 Best Hospitals rankings.

From veteran staff members to undergraduates ready to take on the world, UAB is home to innovators all across campus. Meet 12 people whose stories we were able to share this year, and visit and to read dozens more.

Eligible participants must be healthy adults (BMI less than 45 kg/m2) and have no history of diabetes, heart problems, or kidney problems. The study involves consuming prepared meals, performing exercise on a treadmill, undergoing a glucose test, and collecting blood, urine samples, and collection of genetic information. Participants will be compensated $300 for completing all the visits and meals will be provided at no cost. Please e-mail us at, or call us at (205) 975-3956 if you are interested.
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at
Page 5 of 66